Electrocochleography triggered intervention successfully preserves residual hearing during cochlear implantation: Results of a randomised clinical trial.

Cochlear microphonic auditory nerve neurophonic electrocochleography intraoperative monitoring sensorineural hearing loss

Journal

Hearing research
ISSN: 1878-5891
Titre abrégé: Hear Res
Pays: Netherlands
ID NLM: 7900445

Informations de publication

Date de publication:
12 2022
Historique:
received: 30 06 2021
revised: 19 08 2021
accepted: 15 09 2021
pubmed: 4 10 2021
medline: 7 12 2022
entrez: 3 10 2021
Statut: ppublish

Résumé

Preservation of natural hearing during cochlear implantation is associated with improved speech outcomes, however more than half of implant recipients lose this hearing. Real-time electrophysiological monitoring of cochlear output during implantation, made possible by recording electrocochleography using the electrodes on the cochlear implant, has shown promise in predicting hearing preservation. Sudden drops in the amplitude of the cochlear microphonic (CM) have been shown to predict more severe hearing losses. Here, we report on a randomized clinical trial investigating whether immediate surgical intervention triggered by these drops can save residual hearing. A single-blinded placebo-controlled trial of surgical intervention triggered when CM amplitude dropped by at least 30% of a prior maximum amplitude during cochlear implantation. Intraoperative electrocochleography was recorded in 60 adults implanted with Cochlear Ltd's Thin Straight Electrode, half randomly assigned to a control group and half to an interventional group. The surgical intervention was to withdraw the electrode in ½-mm steps to recover CM amplitude. The primary outcome was hearing preservation 3 months following implantation, with secondary outcomes of speech-in-noise reception thresholds by group or CM outcome, and depth of implantation. Sixty patients were recruited; neither pre-operative audiometry nor speech reception thresholds were significantly different between groups. Post-operatively, hearing preservation was significantly better in the interventional group. This was the case in absolute difference (median of 30 dB for control, 20 dB for interventional, χ² = 6.2, p = .013), as well as for relative difference (medians of 66% for the control, 31% for the interventional, χ² = 5.9, p = .015). Speech-in-noise reception thresholds were significantly better in patients with no CM drop at any point during insertion compared with patients with a CM drop; however, those with successfully recovered CMs after an initial drop were not significantly different (median gain required for speech reception score of 50% above noise of 6.9 dB for no drop, 8.6 for recovered CM, and 9.8 for CM drop, χ² = 6.8, p = .032). Angular insertion depth was not significantly different between control and interventional groups. This is the first demonstration that surgical intervention in response to intraoperative hearing monitoring can save residual hearing during cochlear implantation.

Sections du résumé

BACKGROUND
Preservation of natural hearing during cochlear implantation is associated with improved speech outcomes, however more than half of implant recipients lose this hearing. Real-time electrophysiological monitoring of cochlear output during implantation, made possible by recording electrocochleography using the electrodes on the cochlear implant, has shown promise in predicting hearing preservation. Sudden drops in the amplitude of the cochlear microphonic (CM) have been shown to predict more severe hearing losses. Here, we report on a randomized clinical trial investigating whether immediate surgical intervention triggered by these drops can save residual hearing.
METHODS
A single-blinded placebo-controlled trial of surgical intervention triggered when CM amplitude dropped by at least 30% of a prior maximum amplitude during cochlear implantation. Intraoperative electrocochleography was recorded in 60 adults implanted with Cochlear Ltd's Thin Straight Electrode, half randomly assigned to a control group and half to an interventional group. The surgical intervention was to withdraw the electrode in ½-mm steps to recover CM amplitude. The primary outcome was hearing preservation 3 months following implantation, with secondary outcomes of speech-in-noise reception thresholds by group or CM outcome, and depth of implantation.
RESULTS
Sixty patients were recruited; neither pre-operative audiometry nor speech reception thresholds were significantly different between groups. Post-operatively, hearing preservation was significantly better in the interventional group. This was the case in absolute difference (median of 30 dB for control, 20 dB for interventional, χ² = 6.2, p = .013), as well as for relative difference (medians of 66% for the control, 31% for the interventional, χ² = 5.9, p = .015). Speech-in-noise reception thresholds were significantly better in patients with no CM drop at any point during insertion compared with patients with a CM drop; however, those with successfully recovered CMs after an initial drop were not significantly different (median gain required for speech reception score of 50% above noise of 6.9 dB for no drop, 8.6 for recovered CM, and 9.8 for CM drop, χ² = 6.8, p = .032). Angular insertion depth was not significantly different between control and interventional groups.
CONCLUSIONS
This is the first demonstration that surgical intervention in response to intraoperative hearing monitoring can save residual hearing during cochlear implantation.

Identifiants

pubmed: 34600798
pii: S0378-5955(21)00187-8
doi: 10.1016/j.heares.2021.108353
pii:
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108353

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Christofer Bester (C)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital. Electronic address: christofer.bester@unimelb.edu.au.

Aaron Collins (A)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital.

Tayla Razmovski (T)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital.

Stefan Weder (S)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital; Department of ENT, Head and Neck Surgery, University Hospital, Bern, Switzerland.

Robert J Briggs (RJ)

Department of ENT, RVEEH.

Benjamin Wei (B)

Department of ENT, RVEEH.

Atiqah Farah Zakaria (AF)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital; Department of Otorhinolaryngology, University Putra Malaysia, Malaysia.

Jean-Marc Gerard (JM)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital; Department of ENT, RVEEH.

Alistair Mitchell-Innes (A)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital; Department of ENT, RVEEH.

Michael Tykocinski (M)

Department of ENT, RVEEH.

Richard Kennedy (R)

Department of ENT, RVEEH.

Claire Iseli (C)

Department of ENT, RVEEH.

Markus Dahm (M)

Department of ENT, RVEEH.

Simon Ellul (S)

Department of ENT, RVEEH.

Stephen O'Leary (S)

The University of Melbourne, Department of Surgery and The Royal Victorian Eye and Ear Hospital; Department of ENT, RVEEH. Electronic address: sjoleary@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH